Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 430 | 2,924 | 5,362 | 7,504 | 11,952 |
| Receivables | 389 | 680 | 1,973 | 1,668 | 1,106 |
| Inventories | 765 | 501 | 3,437 | 3,220 | 608 |
| Other current assets | 48 | 2,793 | 0 | 0 | 0 |
| TOTAL | $1,935 | $7,154 | $11,332 | $13,170 | $14,242 |
| Non-Current Assets | |||||
| PPE Net | 53 | 87 | 119 | 193 | 84 |
| Intangibles | 0 | 0 | 2,628 | 9,728 | 0 |
| Other Non-Current Assets | 1,435 | 1,793 | 2,320 | 887 | 912 |
| TOTAL | $1,488 | $1,880 | $5,067 | $10,808 | $996 |
| Total Assets | $3,423 | $9,034 | $16,399 | $23,978 | $15,238 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 500 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 623 | 906 | 1,080 | 1,045 | 302 |
| Accrued Expenses | 1,257 | 1,169 | 2,724 | 2,092 | 2,115 |
| TOTAL | $2,843 | $4,278 | $4,257 | $3,442 | $2,833 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 709 | 1,442 | 1,588 | 10,365 | 87 |
| TOTAL | $709 | $1,442 | $1,588 | $10,365 | $87 |
| Total Liabilities | $3,552 | $5,720 | $5,845 | $13,807 | $2,920 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,816 | 861 | 58 | 42 | 34 |
| Common Shares | 49 | 3 | 20 | 478 | 418 |
| Retained earnings | -183,457 | -174,849 | -158,152 | -141,887 | -136,063 |
| Other shareholders' equity | 6 | 1,950 | 2,973 | 680 | 0 |
| TOTAL | $-129 | $3,314 | $10,554 | $10,171 | $12,318 |
| Total Liabilities And Equity | $3,423 | $9,034 | $16,399 | $23,978 | $15,238 |